Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 5242

BillFederalSenateIn Committee
A bill to provide for digital communication of prescribing information for drugs (including biological products), and for other purposes.
About This Bill
Committee
Latest Action · August 4, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
119th (2025–2027)
Introduced
August 4, 2026
Cosponsors (1)
1D 0R
View PDF ↗

Summary

Highlight any text to annotate
This bill allows pharmaceutical manufacturers to provide prescription drug information to doctors and pharmacists through digital means only, rather than requiring printed copies. Manufacturers must still offer healthcare providers the option to receive or request paper versions of prescribing information at no additional cost. The bill affects anyone involved in prescribing or dispensing medications, including physicians, pharmacists, and drug manufacturers. The Department of Health and Human Services has one year from the bill's enactment to issue regulations explaining how the digital system will work and how providers can obtain paper copies if needed. The new digital requirement would take effect two years after the bill passes, or when the final regulations are issued, whichever comes first.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.